Literature DB >> 14702926

Overview of chemotherapy-induced diarrhea.

Carol S Viele1.   

Abstract

OBJECTIVES: To provide a general overview of chemotherapy-induced diarrhea (CID) that will highlight the pathophysiology, incidence, and impact of this problem, as well as describe the oncology nurse's role in the management of CID. DATA SOURCES: Primary and tertiary literature, the authors' clinical experience.
CONCLUSION: CID is a frequent complication of many types of chemotherapy that can significantly affect patient quality of life, increase treatment costs, and limit the ability to deliver full doses of chemotherapy. Because patients may be reluctant to discuss diarrhea with their health care providers, vigilance on the part of the health care team is needed. IMPLICATIONS FOR NURSING PRACTICE: Through ongoing, regular patient contact, the oncology nurse is uniquely situated to monitor patients for the development of CID, assess its severity, and provide guidance to the health care team on the patient's status.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14702926     DOI: 10.1053/j.soncn.2003.09.007

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  8 in total

Review 1.  Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies.

Authors:  Rachel J Gibson; Dorothy M K Keefe
Journal:  Support Care Cancer       Date:  2006-04-08       Impact factor: 3.603

2.  Evaluation of the Efficacy of the Three-Component Health Care Management Program HEWCOT in Colorectal Cancer Patients Receiving Chemotherapy.

Authors:  Iknur Aydin Avci; Birsen Altay; Figen Cavusoglu; Ayse Cal; Nuran Mumcu; Dilek Celik Eren; Ozge Oz; Alaattin Altin; Ozden Karaoglanoglu; Ayse Buberci
Journal:  J Cancer Educ       Date:  2020-04       Impact factor: 2.037

3.  Cost-effectiveness of adjuvant FOLFOX and 5FU/LV chemotherapy for patients with stage II colon cancer.

Authors:  Mehmet U S Ayvaci; Jinghua Shi; Oguzhan Alagoz; Sam J Lubner
Journal:  Med Decis Making       Date:  2013-01-11       Impact factor: 2.583

4.  Risk of severe diarrhea with dual anti-HER2 therapies: a meta-analysis.

Authors:  Hui Li; Wenyan Fu; Xiang Gao; Qunfang Xu; Hua Wu; Wenlong Tan
Journal:  Tumour Biol       Date:  2013-12-29

Review 5.  Chemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging Treatments.

Authors:  Rachel M McQuade; Vanesa Stojanovska; Raquel Abalo; Joel C Bornstein; Kulmira Nurgali
Journal:  Front Pharmacol       Date:  2016-11-03       Impact factor: 5.810

6.  Development and validation of a patient-reported questionnaire assessing systemic therapy induced diarrhea in oncology patients.

Authors:  Michelle Lui; Daniela Gallo-Hershberg; Carlo DeAngelis
Journal:  Health Qual Life Outcomes       Date:  2017-12-22       Impact factor: 3.186

7.  Impact of an Oral Nutritional Protocol with Oligomeric Enteral Nutrition on the Quality of Life of Patients with Oncology Treatment-Related Diarrhea.

Authors:  Alejandro Sanz-Paris; Javier Martinez-Trufero; Julio Lambea-Sorrosal; Raimon Milà-Villarroel; Fernando Calvo-Gracia
Journal:  Nutrients       Date:  2020-12-29       Impact factor: 5.717

8.  A nanomedicine-promising approach to provide an appropriate colon-targeted drug delivery system for 5-fluorouracil.

Authors:  Sima Singh; Niranjan G Kotla; Sonia Tomar; Balaji Maddiboyina; Thomas J Webster; Dinesh Sharma; Omprakash Sunnapu
Journal:  Int J Nanomedicine       Date:  2015-11-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.